3P innovation Wins Medilink UK Award for cryoFIL® Platform

3P innovation is proud to announce that it has won the prestigious Innovation Award at the Medilink UK National Awards 2025 for its cryoFIL® platform - an advanced robotic system designed to automate and streamline cryovial filling in cell and gene therapy manufacturing.

The award was presented during a ceremony held at the London Institute for Healthcare Engineering (LIHE), where David Johnson and Charles Pilato attended on behalf of the company to accept the honour.

cryoFIL® is a cutting-edge, cGMP-compliant liquid filling platform engineered to address the growing demands of the cell and gene therapy sector. By incorporating 3P innovation’s proven automation technologies, cryoFIL® enables manufacturers to enhance precision, reduce manual handling, and improve overall efficiency in their fill–finish processes.

The Medilink UK Healthcare Business Awards celebrate outstanding achievements and innovation across the UK's life sciences and healthcare technology sectors. Winners are selected from regional Medilink award recipients, showcasing the very best in industry advancements, international success, and contributions to improving healthcare outcomes.

This national recognition reinforces 3P innovation’s commitment to developing scalable, high-performance automation solutions that enable the production of next-generation therapies. The team is honoured to be recognised alongside other pioneering UK companies that are driving progress and improving lives through innovation.